Markets

The Graves’ orbitopathy market is undergoing rapid change, driven by advancements in targeted treatments. TEPEZZA (teprotumumab-trbw) remains the…

(These are the market notes on today’s action by Mike Santoli, CNBC’s Senior Markets Commentator. See today’s video…

Natural gas futures rallied on Thursday after the latest government inventory data proved bullish relative to historical norms…

As of October 2, 2025, the financial markets are witnessing a complex interplay of insider trading activities, reflecting…

Nearly one-fifth of homes for sale in September earned a markdown in the latest sign that the national…

The venerable London Stock Exchange (LSE), a cornerstone of global finance for centuries, finds itself at a critical…

American Century’s chief investment officers offer insights in quarterly investment outlook KANSAS CITY, Mo., Oct. 2, 2025 /PRNewswire/…

Economic headwinds, geopolitical tensions and budget-conscious consumers are creating a perfect storm of uncertainty for retailers. In this…

As European markets navigate the complexities of interest rate policies and trade tensions, major indices like Germany’s DAX…

As global markets navigate through a period of cautious optimism, driven by mixed economic signals and hawkish commentary…

Graves’ Orbitopathy Market to Exhibit Growth at a CAGR of 19.8% During the Forecast Period (2025-2034)